Global Mucopolysaccharidosis (MPS) Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 107 pages | ID: G29008956F2EN
LP Information

Abstracts

According to this study, the global Mucopolysaccharidosis (MPS) Treatment market size will reach US$ million by 2031.

Mucopolysaccharidoses are a group of metabolic disorders caused by the absence or malfunctioning of lysosomal enzymes needed to break down molecules called glycosaminoglycans. These long chains of sugar carbohydrates occur within the cells that help build bone, cartilage, tendons, corneas, skin and connective tissue. Glycosaminoglycans (formerly called mucopolysaccharides) are also found in the fluids that lubricate joints.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Mucopolysaccharidosis (MPS) Treatment Industry Forecast” looks at past sales and reviews total world Mucopolysaccharidosis (MPS) Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Mucopolysaccharidosis (MPS) Treatment sales for 2025 through 2031. With Mucopolysaccharidosis (MPS) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mucopolysaccharidosis (MPS) Treatment industry.

This Insight Report provides a comprehensive analysis of the global Mucopolysaccharidosis (MPS) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Mucopolysaccharidosis (MPS) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mucopolysaccharidosis (MPS) Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mucopolysaccharidosis (MPS) Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mucopolysaccharidosis (MPS) Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Mucopolysaccharidosis (MPS) Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Stem Cell Therapies
• Enzyme Replacement Therapies

Segmentation by Application:

• Hospitals
• Clinics
• Homecare

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Sanofi
• Shire (Takeda)
• BioMarin Pharmaceutical
• Esteve
• REGENXBIO Inc
• Sangamo Therapeutics
• Ultragenyx Pharmaceutical
• Abeona Therapeutics
• ArmaGen
• Eloxx Pharmaceuticals
• Inventiva

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size (2020-2031)
  2.1.2 Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Mucopolysaccharidosis (MPS) Treatment by Country/Region (2020, 2024 & 2031)
2.2 Mucopolysaccharidosis (MPS) Treatment Segment by Type
  2.2.1 Stem Cell Therapies
  2.2.2 Enzyme Replacement Therapies
2.3 Mucopolysaccharidosis (MPS) Treatment Market Size by Type
  2.3.1 Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2020-2025)
2.4 Mucopolysaccharidosis (MPS) Treatment Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Homecare
2.5 Mucopolysaccharidosis (MPS) Treatment Market Size by Application
  2.5.1 Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2020-2025)

3 MUCOPOLYSACCHARIDOSIS (MPS) TREATMENT MARKET SIZE BY PLAYER

3.1 Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Player
  3.1.1 Global Mucopolysaccharidosis (MPS) Treatment Revenue by Player (2020-2025)
  3.1.2 Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Mucopolysaccharidosis (MPS) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MUCOPOLYSACCHARIDOSIS (MPS) TREATMENT BY REGION

4.1 Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2020-2025)
4.2 Global Mucopolysaccharidosis (MPS) Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mucopolysaccharidosis (MPS) Treatment Market Size Growth (2020-2025)
4.4 APAC Mucopolysaccharidosis (MPS) Treatment Market Size Growth (2020-2025)
4.5 Europe Mucopolysaccharidosis (MPS) Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2020-2025)
5.2 Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2020-2025)
5.3 Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2020-2025)
6.2 APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2020-2025)
6.3 APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2020-2025)
7.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2020-2025)
7.3 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment by Region (2020-2025)
8.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MUCOPOLYSACCHARIDOSIS (MPS) TREATMENT MARKET FORECAST

10.1 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Region (2026-2031)
  10.1.1 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Mucopolysaccharidosis (MPS) Treatment Forecast
  10.1.3 APAC Mucopolysaccharidosis (MPS) Treatment Forecast
  10.1.4 Europe Mucopolysaccharidosis (MPS) Treatment Forecast
  10.1.5 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Forecast
10.2 Americas Mucopolysaccharidosis (MPS) Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Mucopolysaccharidosis (MPS) Treatment Forecast
  10.2.2 Canada Market Mucopolysaccharidosis (MPS) Treatment Forecast
  10.2.3 Mexico Market Mucopolysaccharidosis (MPS) Treatment Forecast
  10.2.4 Brazil Market Mucopolysaccharidosis (MPS) Treatment Forecast
10.3 APAC Mucopolysaccharidosis (MPS) Treatment Forecast by Region (2026-2031)
  10.3.1 China Mucopolysaccharidosis (MPS) Treatment Market Forecast
  10.3.2 Japan Market Mucopolysaccharidosis (MPS) Treatment Forecast
  10.3.3 Korea Market Mucopolysaccharidosis (MPS) Treatment Forecast
  10.3.4 Southeast Asia Market Mucopolysaccharidosis (MPS) Treatment Forecast
  10.3.5 India Market Mucopolysaccharidosis (MPS) Treatment Forecast
  10.3.6 Australia Market Mucopolysaccharidosis (MPS) Treatment Forecast
10.4 Europe Mucopolysaccharidosis (MPS) Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Mucopolysaccharidosis (MPS) Treatment Forecast
  10.4.2 France Market Mucopolysaccharidosis (MPS) Treatment Forecast
  10.4.3 UK Market Mucopolysaccharidosis (MPS) Treatment Forecast
  10.4.4 Italy Market Mucopolysaccharidosis (MPS) Treatment Forecast
  10.4.5 Russia Market Mucopolysaccharidosis (MPS) Treatment Forecast
10.5 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Mucopolysaccharidosis (MPS) Treatment Forecast
  10.5.2 South Africa Market Mucopolysaccharidosis (MPS) Treatment Forecast
  10.5.3 Israel Market Mucopolysaccharidosis (MPS) Treatment Forecast
  10.5.4 Turkey Market Mucopolysaccharidosis (MPS) Treatment Forecast
10.6 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Type (2026-2031)
10.7 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Mucopolysaccharidosis (MPS) Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Sanofi
  11.1.1 Sanofi Company Information
  11.1.2 Sanofi Mucopolysaccharidosis (MPS) Treatment Product Offered
  11.1.3 Sanofi Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Sanofi Main Business Overview
  11.1.5 Sanofi Latest Developments
11.2 Shire (Takeda)
  11.2.1 Shire (Takeda) Company Information
  11.2.2 Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Product Offered
  11.2.3 Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Shire (Takeda) Main Business Overview
  11.2.5 Shire (Takeda) Latest Developments
11.3 BioMarin Pharmaceutical
  11.3.1 BioMarin Pharmaceutical Company Information
  11.3.2 BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product Offered
  11.3.3 BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 BioMarin Pharmaceutical Main Business Overview
  11.3.5 BioMarin Pharmaceutical Latest Developments
11.4 Esteve
  11.4.1 Esteve Company Information
  11.4.2 Esteve Mucopolysaccharidosis (MPS) Treatment Product Offered
  11.4.3 Esteve Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Esteve Main Business Overview
  11.4.5 Esteve Latest Developments
11.5 REGENXBIO Inc
  11.5.1 REGENXBIO Inc Company Information
  11.5.2 REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Product Offered
  11.5.3 REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 REGENXBIO Inc Main Business Overview
  11.5.5 REGENXBIO Inc Latest Developments
11.6 Sangamo Therapeutics
  11.6.1 Sangamo Therapeutics Company Information
  11.6.2 Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Product Offered
  11.6.3 Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Sangamo Therapeutics Main Business Overview
  11.6.5 Sangamo Therapeutics Latest Developments
11.7 Ultragenyx Pharmaceutical
  11.7.1 Ultragenyx Pharmaceutical Company Information
  11.7.2 Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product Offered
  11.7.3 Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Ultragenyx Pharmaceutical Main Business Overview
  11.7.5 Ultragenyx Pharmaceutical Latest Developments
11.8 Abeona Therapeutics
  11.8.1 Abeona Therapeutics Company Information
  11.8.2 Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Product Offered
  11.8.3 Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Abeona Therapeutics Main Business Overview
  11.8.5 Abeona Therapeutics Latest Developments
11.9 ArmaGen
  11.9.1 ArmaGen Company Information
  11.9.2 ArmaGen Mucopolysaccharidosis (MPS) Treatment Product Offered
  11.9.3 ArmaGen Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 ArmaGen Main Business Overview
  11.9.5 ArmaGen Latest Developments
11.10 Eloxx Pharmaceuticals
  11.10.1 Eloxx Pharmaceuticals Company Information
  11.10.2 Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Product Offered
  11.10.3 Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Eloxx Pharmaceuticals Main Business Overview
  11.10.5 Eloxx Pharmaceuticals Latest Developments
11.11 Inventiva
  11.11.1 Inventiva Company Information
  11.11.2 Inventiva Mucopolysaccharidosis (MPS) Treatment Product Offered
  11.11.3 Inventiva Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Inventiva Main Business Overview
  11.11.5 Inventiva Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Mucopolysaccharidosis (MPS) Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Stem Cell Therapies
Table 4. Major Players of Enzyme Replacement Therapies
Table 5. Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2020-2025)
Table 8. Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2020-2025)
Table 11. Global Mucopolysaccharidosis (MPS) Treatment Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Player (2020-2025)
Table 13. Mucopolysaccharidosis (MPS) Treatment Key Players Head office and Products Offered
Table 14. Mucopolysaccharidosis (MPS) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Region (2020-2025)
Table 19. Global Mucopolysaccharidosis (MPS) Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Country (2020-2025)
Table 23. Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2020-2025)
Table 25. Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2020-2025)
Table 27. APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Region (2020-2025)
Table 29. APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Country (2020-2025)
Table 33. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Mucopolysaccharidosis (MPS) Treatment
Table 39. Key Market Challenges & Risks of Mucopolysaccharidosis (MPS) Treatment
Table 40. Key Industry Trends of Mucopolysaccharidosis (MPS) Treatment
Table 41. Global Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Sanofi Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 46. Sanofi Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 47. Sanofi Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Sanofi Main Business
Table 49. Sanofi Latest Developments
Table 50. Shire (Takeda) Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 51. Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 52. Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Shire (Takeda) Main Business
Table 54. Shire (Takeda) Latest Developments
Table 55. BioMarin Pharmaceutical Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 56. BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 57. BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. BioMarin Pharmaceutical Main Business
Table 59. BioMarin Pharmaceutical Latest Developments
Table 60. Esteve Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 61. Esteve Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 62. Esteve Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Esteve Main Business
Table 64. Esteve Latest Developments
Table 65. REGENXBIO Inc Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 66. REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 67. REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. REGENXBIO Inc Main Business
Table 69. REGENXBIO Inc Latest Developments
Table 70. Sangamo Therapeutics Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 71. Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 72. Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Sangamo Therapeutics Main Business
Table 74. Sangamo Therapeutics Latest Developments
Table 75. Ultragenyx Pharmaceutical Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 76. Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 77. Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Ultragenyx Pharmaceutical Main Business
Table 79. Ultragenyx Pharmaceutical Latest Developments
Table 80. Abeona Therapeutics Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 81. Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 82. Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Abeona Therapeutics Main Business
Table 84. Abeona Therapeutics Latest Developments
Table 85. ArmaGen Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 86. ArmaGen Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 87. ArmaGen Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. ArmaGen Main Business
Table 89. ArmaGen Latest Developments
Table 90. Eloxx Pharmaceuticals Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 91. Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 92. Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Eloxx Pharmaceuticals Main Business
Table 94. Eloxx Pharmaceuticals Latest Developments
Table 95. Inventiva Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 96. Inventiva Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 97. Inventiva Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Inventiva Main Business
Table 99. Inventiva Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Mucopolysaccharidosis (MPS) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Mucopolysaccharidosis (MPS) Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Mucopolysaccharidosis (MPS) Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Mucopolysaccharidosis (MPS) Treatment Sales Market Share by Country/Region (2024)
Figure 8. Mucopolysaccharidosis (MPS) Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type in 2024
Figure 10. Mucopolysaccharidosis (MPS) Treatment in Hospitals
Figure 11. Global Mucopolysaccharidosis (MPS) Treatment Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Mucopolysaccharidosis (MPS) Treatment in Clinics
Figure 13. Global Mucopolysaccharidosis (MPS) Treatment Market: Clinics (2020-2025) & ($ millions)
Figure 14. Mucopolysaccharidosis (MPS) Treatment in Homecare
Figure 15. Global Mucopolysaccharidosis (MPS) Treatment Market: Homecare (2020-2025) & ($ millions)
Figure 16. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application in 2024
Figure 17. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Player in 2024
Figure 18. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Mucopolysaccharidosis (MPS) Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Mucopolysaccharidosis (MPS) Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Mucopolysaccharidosis (MPS) Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Mucopolysaccharidosis (MPS) Treatment Value Market Share by Country in 2024
Figure 24. United States Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Mucopolysaccharidosis (MPS) Treatment Market Size 2026-2031 ($ millions)